A Nanoparticle-Based Immunoassay on Facemasks for Evaluating Neutrophilic Airway Inflammation in COPD Patients

A Nanoparticle-Based Immunoassay on Facemasks for Evaluating Neutrophilic Airway Inflammation in COPD Patients

Patients with chronic obstructive pulmonary disease (COPD) often experience acute exacerbations characterized by elevated neutrophilic inflammation in the lungs. Currently, this condition is diagnosed through visual inspection of sputum color and volume, a method prone to personal bias and unsuitabl...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bartomeu Mestre, Nuria Toledo-Pons, Andreu Vaquer, Sofia Tejada, Antonio Clemente, Amanda Iglesias, Meritxell López, Ruth Engonga, Sabina Perelló, Borja G. Cosío, Roberto de la Rica
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Series:	Biosensors
Subjects:	chronic obstructive pulmonary disease breath myeloperoxidase exacerbation biosensor
Online Access:	https://www.mdpi.com/2079-6374/15/5/323
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

COPD exacerbation: factors influencing hospitalization duration
by: Gashynova K.Yu.
Published: (2015-03-01)

Do Antidepressants Worsen COPD Outcomes in Depressed Patients with COPD?
by: Alan G. Kaplan
Published: (2024-11-01)

Understanding the Gaps in the Reporting of COPD Exacerbations by Patients: A Review
by: Paul Jones, et al.
Published: (2024-12-01)

Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)

Eosinophil count and treatment response in COPD patients
by: CR Kiran, et al.
Published: (2025-07-01)

Lung IL-13 gene signatures are associated with raised tissue eosinophils in COPD
by: Karl J. Staples, et al.
Published: (2025-03-01)

Variability of blood eosinophil count and prognosis of COPD exacerbations
by: Sandra Martínez-Gestoso, et al.
Published: (2021-01-01)

COPD exacerbation: anthropometric characteristics of patients and the frequency of hospital admissions
by: Gashynova K.Y.
Published: (2014-11-01)

Characterisation of morbidity in a COPD hospital cohort
by: A. Duarte-de-Araújo, et al.
Published: (2019-07-01)

Risk factors for prolonged hospitalization as a marker for difficult-to-manage exacerbations of chronic obstructive lung disease (COPD): the DiMECO Study
by: Dorina Esendağlı, et al.
Published: (2024-11-01)

Clinical characteristic of patients with COPD-A
by: Jong Min Lee, et al.
Published: (2025-05-01)

CLINICAL-PATHOGENIC IMPORTANCE OF CORRELATION BETWEEN HISTOCHEMICAL INDICES OF BLOOD SYSTEM AND RHEUMATOID FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: A B Zborovsky, et al.
Published: (2001-04-01)

Clinical Characteristics and Outcomes of Eosinophilic Exacerbations of COPD
by: Donnan M, et al.
Published: (2025-04-01)

The Burden of COPD with Type 2 Inflammation in North-West Continental Europe
by: Sandelowsky H, et al.
Published: (2025-08-01)

Effectiveness of influenza vaccination in preventing severe COPD exacerbations and pneumonia before, during, and after the COVID-19 pandemic: a retrospective cohort studyResearch in context
by: Sophia Eilat Tsanani, et al.
Published: (2025-06-01)

Influence of anthropometric characteristics on chronic obstructive pulmonary disease (COPD) prognosis in outpatients
by: K. Yu. Gashynova
Published: (2015-06-01)

The role and clinical significance of myeloperoxidase (MPO) and TNF-α in prognostic evaluation of T-COPD
by: E. Jiang, et al.
Published: (2025-04-01)

Impacts of COPD exacerbation history on mortality and severe cardiovascular events among patients with COPD in China: a retrospective cohort study
by: Dongni Hou, et al.
Published: (2025-07-01)

Cumulative Dispensing of Oral Corticosteroids Over 12 Months in People with COPD
by: Burge AT, et al.
Published: (2025-01-01)

Increased MPO concentration but decreased peroxidase activity in saliva of obese women
by: Katarzyna Korybalska, et al.
Published: (2025-05-01)

The Utility of Myeloperoxidase Immunostaining to Characterize Immune Deposits in Patients With Crescentic Glomerulonephritis
by: Rachelle Gietzen, et al.
Published: (2025-05-01)

Association of MPO levels with cardiometabolic disease stratified by atherosclerotic cardiovascular risk and intensity of therapy in a workforce population
by: Olga A. Iakoubova, et al.
Published: (2025-04-01)

Possible in vivo tolerance of human polymorphonuclear neutrophil to low-grade exercise-induced endotoxaemia
by: G. Camus, et al.
Published: (1998-01-01)

Cytokine production of mononuclear leukocytes in response to respiratory syncytial virus is increased in COPD but suppressed in non-COPD tobacco smokers
by: Sarah D. Yanik, et al.
Published: (2025-06-01)

Biomarkers (NLR, PLR, SII) for Frequent COPD Exacerbations: Diagnostic and Clinical Management Implications in a Retrospective Study
by: Fu Y, et al.
Published: (2025-04-01)

Severe exacerbations and mortality in COPD patients: A retrospective analysis of the database of the Hungarian National Health Insurance Fund
by: B. Sánta, et al.
Published: (2023-07-01)

Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD
by: Heemoon Park, et al.
Published: (2025-03-01)

Can Passive Cough Monitoring Predict COPD Exacerbations?
by: A. H. Morice, et al.
Published: (2025-04-01)

DIFFICULTY OF COPD PREDICTING AS A CHALLENGE TO MODERN CLINICAL PULMONOLOGY
by: M. A. Karnaushkina, et al.
Published: (2016-08-01)

Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China
by: Cong Zhang, et al.
Published: (2025-08-01)

Study the effect of compound Extracted from pomegranate peels and green tea on some biochemical variables in rabbit serum induced with Myocardial Infarction
by: Dhamyaa Wajih Yaqoup, et al.
Published: (2022-12-01)

Protective Effect of Pentoxifylline on the Development of Acute Gastric Mucosal Injury in a Model of LPS-Induced Sepsis
by: Sergio D. Paredes, et al.
Published: (2024-12-01)

Management of myeloperoxidase activity of leukocytes in those suffering from community acquired pneumonia with the help of low-intesive lazer radiation of blood
by: N. M. Burduli, et al.
Published: (2016-04-01)

The plasma proteome reveals distinct signaling pathways associated with PR3-ANCA positive and MPO-ANCA positive vasculitis
by: Erik Hellbacher, et al.
Published: (2025-06-01)

Withholding of Life-Sustaining Treatment and Mortality in ICU Patients with Severe Acute COPD Exacerbations: A Retrospective French Cohort
by: Puechoultres P, et al.
Published: (2025-06-01)

Cardiac Dysfunction Indices and Their Prognostic Value in Acute Exacerbation COPD Patients
by: Ahmad B. Elden, et al.
Published: (2020-01-01)

Comorbidities and Cause of Death in COPD Patients Compared to Non-COPD Controls: An 8-year Observational Retrospective Healthcare Claims Database Cohort Study
by: Vogelmeier CF, et al.
Published: (2025-06-01)

No evidence for additional systemic eosinophil mobilization during exacerbations in patients with COPD and chronic bronchitis but no allergy
by: Anders Andersson, et al.
Published: (2025-05-01)

COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD
by: Chen Q, et al.
Published: (2025-06-01)

Patterns of care in the management of high-risk COPD in Australia (2015–2019): an observational study for the CONQUEST quality improvement programResearch in context
by: Christine Jenkins, et al.
Published: (2025-05-01)